Last reviewed · How we verify
Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus Patients (iNCDSS-3)
This is a multi-center, single-blind, parallel group, randomized controlled trial to access the effect and safety of the Artificial Intelligence Assisted Insulin Titration System (iNCDSS) in patients with Type 2 Diabetes Mellitus.
Details
| Lead sponsor | Shanghai Zhongshan Hospital |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 149 |
| Start date | Fri Oct 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Sep 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Type 2 Diabetes
Interventions
- iNCDSS based insulin regime
- routine insulin treatment regime
Countries
China